Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 19, Art. 60 (pp. 819-831)    |    2018       

»

Rationale of glycemic variability measurement in the practice of endocrinologist

Salukhov V.V., Kitсyshin V.P., Ulupova E.O., Titov D.G.

S.M. Kirov Military Medical Academy, Saint Petersburg, Russia

Brief summary

Glycated hemoglobin is the generally accepted standard method for assessment of glycemic compensation. With the advent of continuous glucose monitoring, the role of glycemic variability in the compensation of diabetes mellitus and its micro- and macrovascular complications has been extensively discussed. Many ways of glycemic curve variability measurement have been proposed over the years. Principle methods for glycemic variability measurement, their advantages and limitations, helpful visual schemes are presented in this article. Different methods for assessing the variability of glycemia are structured and classified depending on the technical capabilities and issues, which doctors and researchers may encounter.


Key words

glycemic variability, glycemic curve tests, ADRR, MAGE, CONGA, AUC, GRADE, M-value, J-index, SD, LBGI, HGBI, Lability index.

Reference list

1. Rohlfing C. L. et al. Defining the relationship between plasma glucose and HbA1c: analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial // Diabetes care. - 2002. - Vol. 25. - N. 2. - P. 275-278.


2. Turner R. C. et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) // BMJ. - 1998. - Vol. 316. - N. 7134. - P. 823-828.


3. Monnier L., Colette C. Glycemic variability: should we and can we prevent it? // Diabetes care. - 2008. - Vol. 31. - N. Supplement 2. - P. S150-S154.


4. Ceriello A. et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients // Diabetes. - 2008. - Vol. 57. - N. 5. - P. 1349-1354.


5. Hill N. R. et al. Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups // Diabetes technology & therapeutics. - 2011. - Vol. 13. - P. 9. - S. 921-928.


6. Nomura K. et al. Glycemic profiles of healthy individuals with low fasting plasma glucose and HbA1c // ISRN endocrinology. - 2011. - Article ID 435047.


7. Hanefeld M. et al. Differences in Glycemic Variability Between Normoglycemic and Prediabetic Subjects // J. Diabetes Sci. Technol. - 2014. - Vol. 8. - N2. - P. 286 - 290.


8. Wojciechowski P. et al. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes // Pol. Arch. Med. Wewn. - 2011. - Vol. 121. - N. 10. - P. 333-43.


9. Ceriello A. The glucose triad and its role in comprehensive glycaemic control: current status, future management // Int. J. Clin. Pract. - 2010. - Vol. 64. - N12. - P. 1705 - 1711.


10. DeFronzo R.A. Pathogenesis of type 2 diabetes mellitus // Med. Clin. North Am. - 2004. Vol. 88. - N 4. - P. 787 - 835.


11. Monnier L. et al. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes // Diabetes care. - 2007. - Vol. 30. - N. 2. - P. 263-269.


12. Boden G., Chen X., Urbain J. L. Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production // Diabetes. - 1996. - Vol. 45. - N. 8. -P. 1044-1050.


13. Schlichtkrull J., Munck O., Jersild M. The M-valve, an index of blood-sugar control in diabetics // Acta Med. Scand.- 1965. - Vol. -177. - P. 95 - 102.


14. Cameron F. J., Donath S. M., Baghurst P. A. Measuring glycaemic variation //Current diabetes reviews. - 2010. - Vol. 6. - N. 1. - P. 17 - 26.


15. Zhou J., et al. Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring// Med. Sci. Monit. - 2011.- P. 17. - ?.1.- C. 9 - 13.


16. De Vries J. H. Continuous glucose monitoring: coming of age? // European journal of endocrinology. - 2012. - Vol. 166. - N. 1. - P. 1 - 4.


17. Wójcicki J. M. "J"-index. A new proposition of the assessment of current glucose control in diabetic patients // Horm. Metab. Res.- 1995. - Vol. 27. - N. 1.- P. 41 - 42.


18. Service F. J. Mean amplitude of glycemic excursions, a measure of diabetic instability // Diabetes. -1970. - Vol. 19. - N. 9. - P. 644 - 655.


19. Monnier L. et al. Continuous glucose monitoring in patients with type 2 diabetes: Why? When? Whom? // Diabetes & metabolism. - 2007. - Vol. 33. - N. 4. - P. 247 - 252.


20. Monnier L., Colette C., Owens D. R. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept // Diabetes / Metabolism research and reviews. - 2009. - Vol. 25. - N. 5. - P. 393 - 402.


21. Rodbard D., Jovanovic L., Garg S. K. Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections // Diabetes technology & therapeutics. - 2009. - Vol. 11. - N. 12. - P. 757 - 765.


22. Hill N. R. et al. A method for assessing quality of control from glucose profiles // Diabet Med. - 2007. - Vol. 24. - N. 7. - P. 753 - 758.


23. Kovatchev B. P. Evaluation of a new measure of blood glucose variability in diabetes // Diabetes Care. - 2006. - Vol. 29. - N. 11. - P. 2433 - 2438.


24. Kim S. K. et al. Assessment of glycemic lability and severity of hypoglycemia in Korean patients with type 1 diabetes // Endocr. J. - 2011. - Vol. 58. - N. 6. - P. 433 - 440.


25. Danne T., Nimri R., Battelino T. et al. International consensus on use of continuous glucose monitoring // Diabetes Care. - 2017. - Vol. 40. - P. 1631-1640.


26. Granfeldt Y., Wu X., Björck I. Determination of glycaemic index: some methodological aspects related to the analysis of carbohydrate load and characteristics of the previous evening meal // Eur. J. Clin. Nutr. - 2006. - Vol. 60. - N. 1. - P. 104 - 112.


27. Pochinka I. G., Strongin L. G., Strychkova U. V. Variabelnost glikemii i jelydochkovie narysheniya ritma y bolnih hronicheskoi serdechnoi nedostatochnostu, stradaushih saharnim diabetom 2-go tipa //Kardiologiya. - 2013. - T. 53. - N. 9. - S. 47-51.


28. Klimontov V. V., Myakina N. E. Variabelnost glikemii pri saharnom diabete: instryment dlya ocenki kachestva glikemicheskogo kontrolya i riska oslojnenii // Saharnii diabet. - 2014. - N. 2. - C. 18 - 24.


29. Su G. et al. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes // Cardiovasc. Diabetol. - 2011. - Vol. 10. - N. 19. - P. 1-9.

Журнал основан 16 ноября 2000г.
Выдано Министерством РФ по делам печати, телерадиовещания и средств массовых коммуникаций

(c) Перепечатка материалов сайта Medline.Ru возможна только с письменного разрешения редакции